COCP - Cocrystal Pharma

-

$undefined

N/A

(N/A)

Cocrystal Pharma NASDAQ:COCP Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs.

Location: 19805 N Creek Pkwy, Washington, 98011-8251, US | Website: www.cocrystalpharma.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

1.441M

Cash

18.14M

Avg Qtr Burn

-3.552M

Short % of Float

0.84%

Insider Ownership

30.03%

Institutional Own.

6.68%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.